IvyGene® Plus is a product of Lyman Health LAMH that uses the international cutting-edge methylation detection technology to test for the 7 major cancers with high incidence and lethality (liver cancer, lung cancer, stomach cancer, breast cancer, colorectal cancer, bile duct cancer, and pancreatic cancer). The overall accuracy of the test is >90% and is suitable for people with high risk of 7 types of cancers.